These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9553337

  • 1. [Epidermal growth factor receptors and their ligands as molecular markers of breast cancer prognosis and hormone sensitivity].
    Gershteĭn ES, Kushlinskiĭ NE, Dvorova EK, Kostyleva OI, Muaviia MA, Letiagin VP.
    Klin Lab Diagn; 1998 Feb; (2):9-13. PubMed ID: 9553337
    [No Abstract] [Full Text] [Related]

  • 2. Association of skin rash and tumor response to HER1/EGFR inhibition: does HER1 stimulated tumor growth depend on circulatory instead of paracrine ligands?
    Kurbel S, Faj D.
    Med Hypotheses; 2005 Feb; 64(6):1244-5. PubMed ID: 15823732
    [No Abstract] [Full Text] [Related]

  • 3. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
    Balcan E, Demirkiran F, Aydin Y, Sanioglu C, Bese T, Arvas M, Akçay T, Cift T.
    Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Breast cancer: influence of endocrine hormones, growth factors and genetic alterations.
    Dickson RB, Johnson MD, el-Ashry D, Shi YE, Bano M, Zugmaier G, Ziff B, Lippman ME, Chrysogelos S.
    Adv Exp Med Biol; 1993 Sep; 330():119-41. PubMed ID: 8368129
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review.
    Kjaer IM, Bechmann T, Brandslund I, Madsen JS.
    Clin Chem Lab Med; 2018 Apr 25; 56(5):688-701. PubMed ID: 29194036
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ, George E, Lindgren BR, Niehans GA.
    Hum Pathol; 1994 Oct 25; 25(10):1075-83. PubMed ID: 7927313
    [Abstract] [Full Text] [Related]

  • 14. Hormonal control of growth factor receptor expression.
    De Bortoli M, Maggiora P, Capello D, Antoniotti S, Saviozzi S, Sapei ML, Dati C.
    Ann N Y Acad Sci; 1996 Apr 30; 784():336-48. PubMed ID: 8651582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer.
    Hao C, Li Z, Zhang X, Zhang H, Shang H, Bao J, Wang H.
    Minerva Endocrinol; 2018 Sep 30; 43(3):253-258. PubMed ID: 29125273
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
    Türkeri LN, Erton ML, Cevik I, Akdaş A.
    Urology; 1998 Apr 30; 51(4):645-9. PubMed ID: 9586623
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.